期刊文献+

口服两种剂量黄体酮胶丸的孕激素作用比较 被引量:4

Comparing the progestogen effect of oral progesterone capsule in two kinds of dosage
原文传递
导出
摘要 目的比较口服两种剂量国产黄体酮胶丸的孕激素作用,供临床用药参考。方法选择2004年9月至2005年6月北京协和医院内分泌和妇女健康中心收治的孕激素缺乏患者58例,以开放随机法分为两组:黄体酮胶丸300mg组(29例)及黄体酮胶丸200mg组(29例)。观察两组血清孕酮(P)、基础体温(BBT)、撤药性出血情况、不良反应和肝肾功能。结果(1)口服300mg、200mg黄体酮胶丸后血清孕酮分别为(71.80±41.49)nmol/L和(42.05±20.25)nm01/L,两组比较P〈0.05。(2)两组服药期间基础体温比用药前高约0.2—0.3℃,300mg组达峰值比200mg组约旱3d。(3)共41例患者出现撤药性出血,300mg、200mg组撤药性出血率分别为79.3%和62.1%(P〉0.05)。(4)药物不良反应头晕发生率均为10.3%,300mg、200mg组乳胀发生率分别为17.2%和3.33%;用药前肝肾功能正常,用药后无改变。结论口服黄体酮胶丸300mg和200mg均可以明显升高血清孕酮值,300mg组的孕激素作用比200mg强,但乳胀反应的发生率比后者高。 Objective Comparing the progestogen effect of oral domestic Progesterone capsule (Qining)in two kinds of dosage. Methods A total of 58 patients who lacked progesterone were divided into two groups randomly : Qining 300mg and Qining 200mg group. Observation index : the serum progesterone (P) , basal body temperature (BBT) , withdrawal bleeding,adverse effect and liver and kidney function ( ALT, CR, DBIL) . Results After oral taking of 300mg and 200mg Qining, the serum progesterone level rose notably , being 71.80 ± 41.49nmol/L and 42.05 ± 20.25nmol/L respectively; 41 patients had withdrawal bleeding , and the withdrawal bleeding rate of 300mg and 200 mg group was 79. 3% and 62.1% respectively, which had no significant difference. The main adverse effects were dizziness and breast gas pains, incidence of dizziness being 10. 3% , incidence of breast gas pains 17.2% and 3.33% respectively. Liver and kidney function was normal before taking medicine, which did not change after taking medicine. Conclusion The oral Qining (300mg and 200mg) can raise the serum progesterone level obviously, and the progestogen effect of 300mg group is stronger than 200mg group ,but incidence of breast gas pain is more than the latter.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2008年第8期614-616,共3页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 黄体酮胶丸 孕酮 雌二醇 progesterone capsule progesterone estradiol
  • 相关文献

参考文献5

  • 1James A,Simon MD,Denise E,et al. The Absorption of oral micronized progesterone : the effect of food, dose proportionality, and comparison with intramuscular progesterone [ J ]. Fertil Steril, 1993,60( 1 ) :26-32.
  • 2Costantino DC, Annalidia S, Attilio DSS. Bleeding patterns during continuous estradiol with different sequential progestogens therapy [ J]. Menopause,2005,12:520-525.
  • 3肖碧莲 张旭玲 等.41名中国妇女正常月经周期的生殖激素变化[J].中华医学杂志,1984,64(12):728-731.
  • 4Mona MS, Michael J, Janine D, et al. Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhead[ J ]. Fertil Steril, 1991,56 : 1040-1047.
  • 5Maxson WS, Hargrove JT. Bioavailability of oral micronized progesterone [ J ]. Fertility Sterility, 1985,44:622-626.

共引文献1

同被引文献36

  • 1Lethaby A,Farquhar C,Sarkis A,Roberts H,Jepson R,Barlow D,方爱华.绝经后妇女激素替代治疗:子宫内膜增生和不规则出血[J].生殖与避孕,2006,26(10):618-626. 被引量:4
  • 2Endo T,Henmi H, Goto T, et al. Effects of estradiol and aromatase inhibition on progesterone production in cultured luteal cells [ J ]. Gyneacol Endocnnol, 1998,12 ( 1 ) :29 - 34.
  • 3Goldstein D,Zuckerman H, Harpaz S,et al. Correlation between estradiol and progesterone in cycles with luteal phase defiency [ J]. Fertii Steril, 1982,37 ( 3 ) :348 - 354.
  • 4Pabuccu R,Akar ME. Luteal phase support in assisted reproductive technology [ J ]. Currop in Obstet Gynecol,2005,17 ( 3 ) :277.
  • 5Simon JA, Robinson DE, Andrews MC, et al. The absorption of oral micronized progesterone:the effect of food, dose proportionality and comparison with intramuscular progesterone [ J ]. Fertil Steril, 1993, 60(1) :26 -33.
  • 6Arafat ES, Hargrove JT, Maxson WS, et al. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites [ J ]. Am J Obstet Gynecol, 1988, 159(5) :1203 - 1209.
  • 7King RJ, Whitehead MI. Assessment of the potency of orally administered progestins in women [ J ]. Fertil Steril, 1986, 46 ( 6 ) : 1062 - 1066.
  • 8徐苓.绝经后女性的激素补充新策略--新型连续联合HT制剂雌二醇屈螺酮(安今益)的应用特点概述[N].中国医学论坛报2010年8月26日A13版.
  • 9Sturdee DW, Pines A. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife heahh [ J ]. Climacteric,2011,14:302 - 320.
  • 10Cieraad D, Conradt C, Jesinger D, et al. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/ dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms [ J ]. Arch Gynecol Obstet ,2006,274 (2) :74 - 80.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部